metabolic · Mechanism Report
Does the PEMT rs7946 T allele reduce phosphatidylcholine synthesis and promote liver fat accumulation?
The PEMT rs7946 T allele reduces endogenous phosphatidylcholine synthesis, impairing VLDL assembly and promoting hepatic triglyceride accumulation.
This is what AI claimed
PEMT rs7946 T allele can reduce endogenous phosphatidylcholine synthesis, which can impair VLDL export and promote hepatic fat accumulation.
Executive summary
The claim states that the T allele partially reduces PEMT enzymatic activity, lowering endogenous phosphatidylcholine production and altering the ER membrane PC/PE ratio. This membrane disruption impairs apoB100 lipidation and VLDL budding, causing triglycerides to be retained in hepatocytes and driving hepatic steatosis. The mechanism links a specific genetic variant to a secretory bottleneck that promotes liver fat accumulation.
Verified conclusion
The PEMT gene encodes the enzyme responsible for the endogenous synthesis of phosphatidylcholine (PC) via the methylation of phosphatidylethanolamine (PE) in the liver. Genetic variations in this pathway significantly impact hepatic lipid export and overall metabolic health.
Mechanistic explanations
- Enzymatic reduction: The PEMT rs7946 (V175M) T allele acts as a partial loss-of-function variant, directly reducing PEMT enzymatic activity by approximately 30%.
- Membrane disruption: Rather than just lowering bulk cellular PC, this genetic impairment specifically alters the crucial PC/PE ratio within the endoplasmic reticulum (ER) membrane.
- Assembly failure: An optimal ER membrane PC/PE ratio is strictly required for the cotranslational lipidation of apolipoprotein B100 (apoB100) by microsomal triglyceride transfer protein (MTP). Disrupting this membrane environment impairs apoB100 stabilization and blocks proper VLDL particle budding.
Clinical and physiological evidence
- Impaired secretion: Genetic models of PEMT deficiency (Pemt−/−) exhibit a ~50% reduction in triglyceride secretion and a ~70% drop in apoB100-VLDL export.
- Hepatic lipid trapping: Because VLDL is the primary vehicle for exporting neutral lipids, compromised VLDL assembly causes triglycerides to become physically trapped within hepatocytes. This intracellular pooling shifts the metabolic equilibrium toward cytosolic lipid droplet storage.
- Steatosis susceptibility: This secretory bottleneck directly drives hepatic fat accumulation, increasing susceptibility to non-alcoholic fatty liver disease (NAFLD), especially when dietary choline intake is insufficient to offset the genetic reduction in endogenous PC synthesis.
Bottom line
- The PEMT rs7946 T allele reduces endogenous PC synthesis by 30%, altering the hepatic ER membrane PC/PE ratio and impairing VLDL assembly, which directly traps triglycerides in the liver and promotes hepatic steatosis.
References
- Genetic variants in phosphatidylethanolamine N-methyltransferase and methylenetetrahydrofolate dehydrogenase influence biomarkers of choline metabolism when folate intake is restricted. — pmc.ncbi.nlm.nih.gov
- Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD) — pmc.ncbi.nlm.nih.gov
- PEMT gene - Choline Metabolism & Deficiency - Gene Food — mygenefood.com
- Phosphatidylethanolamine N-methyltransferase - Wikipedia — en.wikipedia.org
- An unexpected requirement for phosphatidylethanolamine N ... — pubmed.ncbi.nlm.nih.gov
- LIPIDS AND LIPOPROTEINS An Unexpected Requirement for ... — sciencedirect.com
- VLDL Biogenesis and Secretion: It Takes a Village - PMC — pmc.ncbi.nlm.nih.gov
- The active synthesis of phosphatidylcholine is required for ... - PubMed — pubmed.ncbi.nlm.nih.gov
- Phosphatidylethanolamine N-methyltransferase: from Functions to ... — pmc.ncbi.nlm.nih.gov
- Phosphatidylcholine biosynthesis and lipoprotein secretion in rat ... — open.library.ubc.ca
- Role of phosphatidylcholine biosynthesis in the regulation ... - PubMed — pubmed.ncbi.nlm.nih.gov
- Steatotic Liver Disease (SLD): Background, Etiology, Pathophysiology — emedicine.medscape.com
- Lipid and Lipoprotein Metabolism in Liver Disease - Endotext - NCBI — ncbi.nlm.nih.gov
- Dysfunctional VLDL metabolism in MASLD - Nature — nature.com
- NAFLD: Mechanisms, Treatments, and Biomarkers - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Metabolic-associated fatty liver disease and lipoprotein metabolism — pmc.ncbi.nlm.nih.gov
- Blocking VLDL secretion causes hepatic steatosis but does not ... — pubmed.ncbi.nlm.nih.gov
- Metabolic-associated fatty liver disease and lipoprotein metabolism — sciencedirect.com
- Lack of phosphatidylethanolamine N-methyltransferase ... - PubMed — pubmed.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough